Stifel Financial Corp Has $24.68 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Stifel Financial Corp raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 17.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 262,924 shares of the company's stock after acquiring an additional 39,094 shares during the quarter. Stifel Financial Corp owned 0.06% of GE HealthCare Technologies worth $24,676,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Mesirow Financial Investment Management Inc. lifted its holdings in GE HealthCare Technologies by 39.6% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company's stock valued at $383,000 after acquiring an additional 1,159 shares during the last quarter. LMR Partners LLP acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $7,387,000. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $1,396,000. Bank of Montreal Can lifted its holdings in GE HealthCare Technologies by 27.5% in the 2nd quarter. Bank of Montreal Can now owns 696,446 shares of the company's stock valued at $54,964,000 after acquiring an additional 150,137 shares during the last quarter. Finally, Douglas Lane & Associates LLC lifted its holdings in GE HealthCare Technologies by 2.2% in the 3rd quarter. Douglas Lane & Associates LLC now owns 460,004 shares of the company's stock valued at $43,171,000 after acquiring an additional 10,099 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.27% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Stock Up 0.8 %

Shares of NASDAQ GEHC traded up $0.66 during mid-day trading on Monday, reaching $81.90. The company had a trading volume of 2,372,598 shares, compared to its average volume of 3,052,767. The stock has a fifty day moving average of $86.80 and a two-hundred day moving average of $83.68. GE HealthCare Technologies Inc. has a 12-month low of $69.09 and a 12-month high of $94.55. The company has a market capitalization of $37.42 billion, a price-to-earnings ratio of 22.32, a PEG ratio of 2.91 and a beta of 1.08. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping analysts' consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. During the same quarter in the prior year, the company posted $0.99 earnings per share. The firm's revenue was up .9% on a year-over-year basis. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. GE HealthCare Technologies's dividend payout ratio is currently 3.30%.

Analysts Set New Price Targets

A number of analysts have commented on GEHC shares. BTIG Research raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price objective for the company in a research note on Wednesday, September 18th. UBS Group lowered shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and reduced their price objective for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a research note on Thursday, October 31st. Stifel Nicolaus upped their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a research note on Monday, September 30th. Finally, JPMorgan Chase & Co. started coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a "neutral" rating and a $90.00 price objective for the company. One research analyst has rated the stock with a sell rating, four have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and an average target price of $95.46.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.